%0 Journal Article
%T Bioptically Proven ¡°Anticoagulation-Related Nephropathy¡° Induced by Dual Antiplatelet Therapy
%A Eva Honsov¨¢
%A Ivan Rychl¨ªk
%A Karol¨ªna Kr¨¢tk¨¢
%A Martin Havrda
%J Archive of "Case Reports in Nephrology and Dialysis".
%D 2018
%R 10.1159/000493093
%X Anticoagulation-related nephropathy (ARN) is a significant and underdiagnosed complication in patients who receive anticoagulation therapy. It is characterized by acute kidney injury in the setting of excessive anticoagulation defined as an international normalized ratio > 3.0 in patients treated with warfarin. A definitive diagnosis is made by renal biopsy showing acute tubular necrosis with obstruction of the tubuli by red blood cell casts. However, the evidence shows that ARN can occur during treatment with novel oral anticoagulants as well. Although it has been suggested that antiplatelet therapy, such as aspirin, might contribute to coagulopathy (and therefore the hypothetical risk of ARN), there are no reports of ARN induced by antiplatelet therapy according to our knowledge. It is also reported that glomerular lesions (i.e., kidney disease) represent a risk factor for ARN. We present a case of an 82-year-old man who developed biopsy-proven ARN after the administration of dual antiplatelet therapy with no previous anticoagulation treatment and normal coagulation tests
%K Acute kidney injury
%K Anticoagulation-related nephropathy
%K Hematuria
%K Dual antiplatelet therapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206970/